{"id":"NCT04739709","sponsor":"Formosa Pharmaceuticals, Inc.","briefTitle":"Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery","officialTitle":"A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-01-11","primaryCompletion":"2022-03-17","completion":"2022-03-17","firstPosted":"2021-02-05","resultsPosted":"2023-07-05","lastUpdate":"2023-07-20"},"enrollment":378,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ocular Inflammation and Pain"],"interventions":[{"type":"DRUG","name":"APP13007, 0.05%","otherNames":[]},{"type":"DRUG","name":"Matching Vehicle Placebo for APP13007, 0.05%","otherNames":[]}],"arms":[{"label":"APP13007 0.05% BID","type":"EXPERIMENTAL"},{"label":"Matching Vehicle Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This Phase 3 study will evaluate APP13007 in comparison to the matching vehicle placebo in a randomized, parallel-group, double-masked fashion. The subjects will have undergone routine cataract surgery on Day 0 of the study and will be assessed the next day (Post-operative Day 1; POD1) after uncomplicated surgery for eligibility for randomization to study treatment.","primaryOutcome":{"measure":"Participants With ACC Count = 0 at All Visits From Postoperative Day 8 Through Postoperative Day 15 Without Rescue Medication","timeFrame":"Postoperative Day 8 and Postoperative Day 15","effectByArm":[{"arm":"APP13007 0.05% BID","deltaMin":48,"sd":null},{"arm":"Matching Vehicle Placebo","deltaMin":10,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":35,"countries":["United States","Puerto Rico"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":181},"commonTop":["Corneal oedema"]}}